321
Views
13
CrossRef citations to date
0
Altmetric
Themed article: ADHD - Review

An ‘integrative neuroscience’ perspective on ADHD: linking cognition, emotion, brain and genetic measures with implications for clinical support

, , &
Pages 1607-1621 | Published online: 09 Jan 2014

References

  • Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol. Psychiatry44(10), 951–958 (1998).
  • Jensen PS, Martin D, Cantwell DP. Comorbidity in ADHD: implications for research, practice, and DSM-V. J. Am. Acad. Child Adolesc. Psychiatry36(8), 1065–1079 (1997).
  • Biederman J. Attention-deficit/hyperactivity disorder: a life-span perspective. J. Clin. Psychiatry59(Suppl. 7), 4–16 (1998).
  • Barkley RA. Attention-deficit hyperactivity disorder. Sci. Am.279(3), 66–71 (1998).
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. American Psychiatric Association, DC, USA (1994).
  • Murphy KR, Barkley RA, Bush T. Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational, and clinical history. J. Nerv. Ment. Dis.190(3), 147–157 (2002).
  • Charney DS, Barlow DH, Botteron K et al. Neuroscience research agenda to guide development of a pathophysiologically based classification system. In: A Research Agenda for DSM-V. Kupfer DJ, First MB, Reiger DA (Eds). American Psychiatric Association, DC, USA (2002).
  • Castellanos FX, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci.3(8), 617–628 (2002).
  • Insel TR, Volkow ND, Landis SC et al. Limits to growth: why neuroscience needs large-scale science. Nat. Neurosci.7(5), 426–427 (2004).
  • Gordon E, Liddell BJ, Brown KJ et al. Integrating objective gene–brain–behavior markers of psychiatric disorders. J. Integr. Neurosci.6(1), 1–34 (2007).
  • Monastra VJ. Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach. Int. J. Psychophysiol.58(1), 71–80 (2005).
  • Gordon E. Integrative genomics and neuromarkers for the era of brain related personalized medicine. Personalized Medicine4(2), 201–215 (2007).
  • Barkley RA. ADHD And The Nature Of Self-Control. Guilford Press, NY, USA (1997).
  • Bush G, Valera EM, Seidman LJ. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol. Psychiatry57(11), 1273–1284 (2005).
  • Gordon E, Cooper N, Rennie C, Hermens D, Williams LM. Integrative neuroscience: the role of a standardized database. Clin. EEG Neurosci.36(2), 64–75 (2005).
  • Gordon E, Barnett KJ, Cooper NJ, Tran N, Williams LM. An ‘integrative neuroscience’ platform: application to profiles of negativity and positivity bias. J. Integr. Neurosci.7(3), 345–366 (2008).
  • Williams LM, Gatt JM, Hatch A et al. The INTEGRATE model of emotion, thinking and self regulation: an application to the ‘paradox of aging’. J. Integr. Neurosci.7(3), 367–404 (2008).
  • Williams LM, Hermens DF, Thein T et al. Using brain-based cognitive measures to support clinical decisions in ADHD. Pediatr. Neurol.42(2), 118–126 (2010).
  • Quay HC. Inhibition and attention deficit hyperactivity disorder. J. Abnorm. Child Psychol.25(1), 7–13 (1997).
  • Sergeant JA, Geurts H, Huijbregts S, Scheres A, Oosterlaan J. The top and the bottom of ADHD: a neuropsychological perspective. Neurosci. Biobehav. Rev.27(7), 583–592 (2003).
  • Sergeant JA. The cognitive–energetic model: an empirical approach to attention-deficit hyperactivity disorder. Neurosci. Biobehav. Rev.24(1), 7–12 (2000).
  • Hermens DF, Kohn MR, Clarke SD, Gordon E, Williams LM. Sex differences in adolescent ADHD: findings from concurrent EEG and EDA. Clin. Neurophysiol.116(6), 1455–1463 (2005).
  • Hermens DF, Soei EXC, Clarke SD et al. Resting EEG theta activity predicts cognitive performance in attention-deficit hyperactivity disorder. Pediatr. Neurol.32(4), 248–256 (2005).
  • Loo SK, Hopfer C, Teale PD, Reite ML. EEG correlates of methylphenidate response in ADHD: association with cognitive and behavioral measures. J. Clin. Neurophysiol.21(6), 457–464 (2004).
  • Snyder SM, Quintana H, Sexson SB et al. Blinded, multi-center validation of EEG and rating scales in identifying ADHD within a clinical sample. Psychiatry Res.159(3), 346–358 (2008).
  • Chabot RJ, Serfontein G. Quantitative electroencephalographic profiles of children with attention deficit disorder. Biol. Psychiatry40(10), 951–963 (1996).
  • Whitford TJ, Rennie CJ, Grieve SM et al. Brain maturation in adolescence: concurrent changes in neuroanatomy and neurophysiology. Hum. Brain Mapp.28(3), 228–237 (2007).
  • Hermens DF, Williams LM, Lazzaro I et al. Sex differences in adult ADHD: a double dissociation in brain activity and autonomic arousal. Biol. Psychol.66(3), 221–233 (2004).
  • Duffy FH, Burchfiel JL, Lombroso CT. Brain electrical activity mapping (BEAM): a method for extending the clinical utility of EEG and evoked potential data. Ann. Neurol.5(4), 309–321 (1979).
  • The Royal Australasian College of Physicians. Australian guidelines on attention deficit hyperactivity disorder (ADHD). The Royal Australasian College of Physicians, New South Wales, Australia (2009).
  • Monastra VJ. Quantitative electroencephalography and attention-deficit/hyperactivity disorder: implications for clinical practice. Curr. Psychiatry Rep.10(5), 432–438 (2008).
  • Barry RJ, Johnstone SJ, Clarke AR. A review of electrophysiology in attention-deficit/hyperactivity disorder: II. Event-related potentials. Clin. Neurophysiol.114(2), 184–198 (2003).
  • Callaway E, Halliday R, Naylor H. Hyperactive children’s event-related potentials fail to support underarousal and maturational-lag theories. Arch. Gen. Psychiatry40(11), 1243–1248 (1983).
  • Hermens DF, Williams LM, Clarke S et al. Responses to methylphenidate in adolescent AD/HD: evidence from concurrently recorded autonomic (EDA) and central (EEG and ERP) measures. Int. J. Psychophysiol.58(1), 21–33 (2005).
  • Johnstone SJ, Barry RJ. Auditory event-related potentials to a two-tone discrimination paradigm in attention deficit hyperactivity disorder. Psychiatry Res.64(3), 179–192 (1996).
  • Yong-Liang G, Robaey P, Karayanidis F et al. ERPs and behavioral inhibition in a Go/No-go task in children with attention-deficit hyperactivity disorder. Brain Cogn.43(1–3), 215–220 (2000).
  • Tamm L, Menon V, Reiss AL. Parietal attentional system aberrations during target detection in adolescents with attention deficit hyperactivity disorder: event-related fMRI evidence. Am. J. Psychiatry163(6), 1033–1043 (2006).
  • Bush G. Dorsal anterior midcingulate cortex: roles in normal cognition and disruption in attention-deficit/hyperactivity disorder. In: Cingulate Neurobiology and Disease. Vogt BA (Ed.). Oxford University Press, NY, USA, 207–218 (2009).
  • Dickstein SG, Bannon K, Castellanos FX, Milham MP. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J. Child Psychol. Psychiatry47(10), 1051–1062 (2006).
  • Rubia K, Overmeyer S, Taylor E et al. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am. J. Psychiatry156(6), 891–896 (1999).
  • Vance A, Silk TJ, Casey M et al. Right parietal dysfunction in children with attention deficit hyperactivity disorder, combined type: a functional MRI study. Mol. Psychiatry12(9), 826–832 (2007).
  • Durston S, Davidson MC, Thomas KM et al. Parametric manipulation of conflict and response competition using rapid mixed-trial event-related fMRI. Neuroimage20(4), 2135–2141 (2003).
  • Williams LM, Felmingham K, Kemp AH et al. Mapping frontal-limbic correlates of orienting to change detection. Neuroreport18(3), 197–202 (2007).
  • Cortese S, Faraone SV, Konofal E, Lecendreux M. Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J. Am. Acad. Child Adolesc. Psychiatry48(9), 894–908 (2009).
  • Sharp SI, McQuillin A, Gurling HM. Genetics of attention-deficit hyperactivity disorder (ADHD). Neuropharmacology57(7–8), 590–600 (2009).
  • Cornish KM, Manly T, Savage R et al. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol. Psychiatry10(7), 686–698 (2005).
  • Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum. Genet.126(1), 51–90 (2009).
  • Weingartner H, Rapoport JL, Buchsbaum MS et al. Cognitive processes in normal and hyperactive children and their response to amphetamine treatment. J. Abnorm. Psychol.89(1), 25–37 (1980).
  • Bedard A-C, Tannock R. Anxiety, methylphenidate response, and working memory in children with ADHD. J. Atten. Disord.11(5), 546–557 (2008).
  • Losier BJ, McGrath PJ, Klein RM. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J. Child Psychol. Psychiatry37(8), 971–987 (1996).
  • Sostek AJ, Buchsbaum MS, Rapoport JL. Effects of amphetamine on vigilance performance in normal and hyperactive children. J. Abnorm. Child Psychol.8(4), 491–500 (1980).
  • Taylor MJ, Voros JG, Logan WJ, Malone MA. Changes in event-related potentials with stimulant medication in children with attention deficit hyperactivity disorder. Biol. Psychology36(3), 139–156 (1993).
  • Sunohara GA, Voros JG, Malone MA, Taylor MJ. Effects of methylphenidate in children with attention deficit hyperactivity disorder: a comparison of event-related potentials between medication responders and non-responders. Int. J. Psychophysiol.27(1), 9–14 (1997).
  • Loo SK, Teale PD, Reite ML. EEG correlates of methylphenidate response among children with ADHD: a preliminary report. Biol. Psychiatry45(12), 1657–1660 (1999).
  • Clarke AR, Barry RJ, McCarthy R et al. Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder predominantly inattentive type. Int. J. Psychophysiol.47(2), 129–137 (2003).
  • Klorman R, Brumaghim JT, Salzman LF et al. Effects of methylphenidate on processing negativities in patients with attention-deficit hyperactivity disorder. Psychophysiology27(3), 328–337 (1990).
  • Williams LM, Hermens DF, Kohn M, Clarke S, Gordon E. Integrating cognitive and affective markers of ADHD. NDTS74 (2006).
  • Keage HA, Clark CR, Hermens DF et al. ERP indices of working memory updating in AD/HD: differential aspects of development, subtype, and medication. J. Clin. Neurophysiol.25(1), 32–41 (2008).
  • Gruber R, Joober R, Grizenko N et al. Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder. J. Child Adolesc. Psychopharmacol.19(3), 233–239 (2009).
  • Cadesky EB, Mota VL, Schachar RJ. Beyond words: how do children with ADHD and/or conduct problems process nonverbal information about affect? J. Am. Acad. Child Adolesc. Psychiatry39(9), 1160–1167 (2000).
  • Corbett B, Glidden H. Processing affective stimuli in children with attention-deficit hyperactivity disorder. Child Neuropsychol.6(2), 144–155 (2000).
  • Downs A, Smith T. Emotional understanding, cooperation, and social behavior in high-functioning children with autism. J. Autism Dev. Disord.34(6), 625–635 (2004).
  • Pelc K, Kornreich C, Foisy M-L, Dan B. Recognition of emotional facial expressions in attention-deficit hyperactivity disorder. Pediatr. Neurol.35(2), 93–97 (2006).
  • Shapiro EG, Hughes SJ, August GJ, Bloomquist ML. Processing of emotional information in children with attention-deficit hyperactivity disorder. Dev. Neuropsychol.9, 207–224 (1993).
  • Williams LM, Hermens DF, Palmer D et al. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects. Biol. Psychiatry63(10), 917–926 (2008).
  • Sonuga-Barke EJ. Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol. Psychiatry57(11), 1231–1238 (2005).
  • Nigg JT, Casey BJ. An integrative theory of attention-deficit/hyperactivity disorder based on the cognitive and affective neurosciences. Dev. Psychopathol.17(3), 785–806 (2005).
  • Marsh AA, Finger EC, Mitchell DG et al. Reduced amygdala response to fearful expressions in children and adolescents with callous-unemotional traits and disruptive behavior disorders. Am. J. Psychiatry165(6), 712–720 (2008).
  • Thapar A, Langley K, Fowler T et al. Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry62(11), 1275–1278 (2005).
  • Williams LM, Gatt JM, Grieve SM et al.COMT Val(108/158)Met polymorphism effects on emotional brain function and negativity bias. Neuroimage53(3), 918–925 (2010).
  • Culpepper L. Primary care treatment of attention-deficit/hyperactivity disorder. J. Clin. Psychiatry67(Suppl. 8), 51–58 (2006).
  • MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch. Gen. Psychiatry56(12), 1073–1086 (1999).
  • Biederman J. Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am. J. Psychiatry148, 564–577 (1991).
  • Biederman J, Mick E, Faraone SV et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am. J. Psychiatry159(1), 36–42 (2002).
  • Rapport LJ, Friedman SR, Tzelepis A, Van Voorhis A. Experienced emotion and affect recognition in adult attention-deficit hyperactivity disorder. Neuropsychology16(1), 102–110 (2002).
  • Gabriela ML, John DG, Magdalena BV et al. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients. Neurosci. Lett.451(3), 257–260 (2009).
  • Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J. Clin. Psychiatry59(Suppl. 7), 50–58 (1998).
  • Pliszka SR, Crismon ML, Hughes CW et al. The Texas Children’s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry45(6), 642–657 (2006).
  • Nigg JT. Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biol. Psychiatry57(11), 1424–1435 (2005).
  • Perner J, Kain W, Barchfeld P. Executive control and higher-order theory of mind in children at risk of ADHD. Infant Child Dev.11, 141–158 (2002).
  • Braaten EB, Rosen LA. Self-regulation of affect in attention deficit-hyperactivity disorder (ADHD) and non-ADHD boys: differences in empathic responding. J. Consult. Clin. Psychol.68(2), 313–321 (2000).
  • Crundwell RM. An initial investigation of the impact of self-regulation and emotionality on behavior problems in children with ADHD. Can. J. Sch. Psychol.20, 62 (2005).
  • Gilmour J, Hill B, Place, M, Skuse DH. Social communication deficits in conduct disorder: a clinical and community survey. J. Child Psychol. Psychiatry45(5), 967–978 (2004).
  • Mikami AY, Pfiffner LJ. Sibling relationships among children with ADHD. J. Atten. Disord.11(4), 482–492 (2008).
  • Hinshaw SP, Henker, B, Whalen CK. Self-control in hyperactive boys in anger-inducing situations: effects of cognitive-behavioral training and of methylphenidate. J. Abnorm. Child Psychol.12(1), 55–77 (1984).
  • Reid JB, Eddy JM, Fetrow RA, Stoolmiller M. Description and immediate impacts of a preventive intervention for conduct problems. Am. J. Community Psychol.27(4), 483–517 (1999).
  • Webster-Stratton C, Reid J, Hammond M. Social skills and problem-solving training for children with early-onset conduct problems: who benefits? J. Child Psychol. Psychiatry42(7), 943–952 (2001).
  • van Manen TG, Prins PJ, Emmelkamp PM. Reducing aggressive behavior in boys with a social cognitive group treatment: results of a randomized, controlled trial. J. Am. Acad. Child Adolesc. Psychiatry43(12), 1478–1487 (2004).
  • Overmeyer S, Bullmore ET, Suckling J et al. Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network. Psychol. Med.31(8), 1425–1435 (2001).
  • Castellanos FX, Giedd JN, Marsh WL et al. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry53(7), 607–616 (1996).
  • Kates WR, Frederikse M, Mostofsky SH et al. MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome. Psychiatry Res.116(1–2), 63–81 (2002).
  • Semrud-Clikeman M, Steingard RJ, Filipek P et al. Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity. J. Am. Acad. Child Adolesc. Psychiatry39(4), 477–484 (2000).
  • Shaw P, Lerch J, Greenstein D et al. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry63(5), 540–549 (2006).
  • Shaw P, Eckstrand K, Sharp W et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc. Nat. Acad. Sci. USA104(49), 19649–19654 (2007).
  • Niederhofer H, Menzel F, Gobel K et al. A preliminary report of the dopamine receptor D4 and the dopamine transporter 1 gene polymorphism and its association with attention deficit hyperactivity disorder. Neuropsychiatr. Dis. Treat.4(4), 701–705 (2008).
  • Marton I, Wiener J, Rogers M, Moore C, Tannock R. Empathy and social perspective taking in children with attention-deficit/hyperactivity disorder. J. Abnorm. Child Psychol.37, 107–118 (2009).
  • Servera M, Cardo E, Brunet J et al. Accuracy of the Children Sustained Attention Task (CSAT) in the ADHD diagnosis. Preliminary data. Presented at: 38th EABCT Annual Congress. Helsinki, Finland, 10–13 September 2008.
  • Kohn M, Clarke S, Williams LM. Personalized integrative markers for attention deficit/hyperactivity disorder in children and adolescents. In: Personalized Medicine for the Brain. Koslow SH, Gordon E (Eds). Oxford University Press, NY, USA (2010).
  • Satterfield JH, Cantwell DP, Satterfield BT. Pathophysiology of the hyperactive child syndrome. Arch. Gen. Psychiatry31(6), 839–844 (1974).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.